{"id":"NCT03021499","sponsor":"Aurinia Pharmaceuticals Inc.","briefTitle":"Aurinia Renal Response in Active Lupus With Voclosporin","officialTitle":"A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-05-17","primaryCompletion":"2019-09-24","completion":"2019-10-10","firstPosted":"2017-01-16","resultsPosted":"2021-06-16","lastUpdate":"2023-03-27"},"enrollment":358,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lupus Nephritis"],"interventions":[{"type":"DRUG","name":"Voclosporin","otherNames":["ISA247"]},{"type":"DRUG","name":"Placebo Oral Capsule","otherNames":[]}],"arms":[{"label":"Voclosporin","type":"EXPERIMENTAL"},{"label":"Placebo Oral Capsule","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy of voclosporin compared with placebo in achieving renal response after 52 weeks of therapy in subjects with active lupus nephritis.","primaryOutcome":{"measure":"Number of Participants With Adjudicated Renal Response at Week 52","timeFrame":"52 Weeks","effectByArm":[{"arm":"Voclosporin","deltaMin":73,"sd":null},{"arm":"Placebo Oral Capsule","deltaMin":40,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":185,"countries":["United States","Argentina","Belarus","Brazil","Bulgaria","Canada","Chile","Colombia","Costa Rica","Croatia","Dominican Republic","Guatemala","Japan","Malaysia","Mexico","Netherlands","North Macedonia","Peru","Philippines","Poland","Puerto Rico","Russia","Serbia","South Africa","South Korea","Spain","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine","Vietnam"]},"refs":{"pmids":["22879439","24330024","23996158","23736966","22087680","21943027","40166657","38110196","33971155"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":37,"n":178},"commonTop":["Glomerular filtration rate decreased","Upper respiratory tract infection","Diarrhoea","Hypertension","Headache"]}}